Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Learn more about the possibilities of this page

Biogen Inc. Stock

Price
Target price
€192.00

€192.00

1.690%
3.2
1.690%
€294.45
 
16:30 / Tradegate WKN: 789617 / Symbol: BIIB / Name: Biogen / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Biogen Inc. in the next few years
Wizard

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Biogen Inc. is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Biogen

sharewise wants to provide you with the best news and tools for Biogen, so we directly link to the best financial data sources.

Financials

News

Broker

 

News

Why Biogen Stock Leaped Nearly 5% Higher Today: https://g.foolcdn.com/editorial/images/774248/person-in-a-lab-looking-through-a-microscope.jpg
Why Biogen Stock Leaped Nearly 5% Higher Today

Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded

TheMotleyFool 
0 25.04.24
Biogen (BIIB) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Biogen (BIIB) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Biogen (NASDAQ: BIIB)Q1 2024 Earnings CallApr 24, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

TheMotleyFool 
0 24.04.24
1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223?: https://g.foolcdn.com/editorial/images/767026/scientist-works-at-lab-bench.jpg
1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223?

On Feb. 20, Cantor Fitzgerald analyst Eric Schmidt restated his aggressive price target for Biogen, (NASDAQ: BIIB) estimating that the biopharmaceutical stock will rise by 39% to reach roughly $311

TheMotleyFool 
0 02.03.24
Biogen (BIIB) Q4 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Biogen (BIIB) Q4 2023 Earnings Call Transcript

Image source: The Motley Fool.

Biogen (NASDAQ: BIIB)Q4 2023 Earnings CallFeb 13, 2024, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

TheMotleyFool 
0 13.02.24
Why Eli Lilly Stock Could Start Off 2024 With a Bang: https://g.foolcdn.com/editorial/images/759509/businessperson-giving-a-presentation.jpg
Why Eli Lilly Stock Could Start Off 2024 With a Bang

Eli Lilly (NYSE: LLY) has been one of the hottest healthcare stocks to own in recent years. The company is now the most valuable healthcare company in the world, with a valuation of around $550

TheMotleyFool 
0 01.01.24
2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond: https://g.foolcdn.com/editorial/images/756670/person-working-in-a-cannabis-dispensary.jpg
2 Popular Stocks to Avoid Like the Plague in 2024 and Beyond

One famous investing maxim advises to buy low and sell high. That's sage advice, but not all stocks are worth investing in while they are down. If they don't go up, you won't have profited from the

TheMotleyFool 
0 09.12.23
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?: https://g.foolcdn.com/editorial/images/754325/doctor-presents-data-to-colleagues-at-table.jpg
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?

It's a no-brainer to invest in businesses that are making headway in the growth markets of the future. In biopharma, therapies to treat or prevent Alzheimer's disease constitute one such growth

TheMotleyFool 
0 10.11.23
Biogen (BIIB) Q3 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Biogen (BIIB) Q3 2023 Earnings Call Transcript

Image source: The Motley Fool.

Biogen (NASDAQ: BIIB)Q3 2023 Earnings CallNov 08, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

TheMotleyFool 
0 08.11.23